Search

everythinglearnresearchcommunity

for

Search:↓

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Blocking Prostaglandin D₂ may help treat hair loss.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Recent advances in hair loss treatments show significant progress.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The leaf extract of Leea indica may reduce inflammation, dissolve blood clots, and promote hair growth.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

The inhibitor DPP can promote hair growth.

Juniperus plants contain compounds with potential for developing various medical treatments.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.